These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12557259)

  • 1. Exploring environmental causes of altered ras effects: fragmentation plus integration?
    Porta M; Ayude D; Alguacil J; Jariod M
    Mol Carcinog; 2003 Feb; 36(2):45-52. PubMed ID: 12557259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In pancreatic ductal adenocarcinoma blood concentrations of some organochlorine compounds and coffee intake are independently associated with KRAS mutations.
    Porta M; López T; Pumarega J; Jariod M; Crous-Bou M; Marco E; Rifà J; Grimalt JO; Malats N; Real FX;
    Mutagenesis; 2009 Nov; 24(6):513-21. PubMed ID: 19797353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
    Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
    Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative influence of diet and serum concentrations of organochlorine compounds on K-ras mutations in exocrine pancreatic cancer.
    Gasull M; Porta M; Pumarega J; Vioque J; Bosch de Basea M; Puigdomènech E; Morales E; Grimalt JO; Malats N
    Chemosphere; 2010 Apr; 79(7):686-97. PubMed ID: 20350743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
    Porta M; Malats N; Guarner L; Carrato A; Rifà J; Salas A; Corominas JM; Andreu M; Real FX
    J Epidemiol Community Health; 1999 Nov; 53(11):702-9. PubMed ID: 10656099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer.
    Crous-Bou M; Porta M; López T; Jariod M; Malats N; Alguacil J; Morales E; Fernandez E; Corominas JM; Carrato A; Guarner L; Real FX;
    Pancreas; 2007 Aug; 35(2):135-41. PubMed ID: 17632319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of pancreatic cancer.
    Li D
    Cancer J; 2001; 7(4):259-65. PubMed ID: 11561602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal adenomas with a low frequency of ki-ras mutations: a sample from a population with a low mortality rate from colorectal cancer.
    Kornaros S; Liloglou T; Politou M; Elemenoglou I
    Colorectal Dis; 2005 Jul; 7(4):323-6. PubMed ID: 15932552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
    Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
    Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer.
    Plowman SJ; Berry RL; Bader SA; Luo F; Arends MJ; Harrison DJ; Hooper ML; Patek CE
    J Exp Clin Cancer Res; 2006 Jun; 25(2):259-67. PubMed ID: 16918139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study.
    Crous-Bou M; Porta M; Morales E; López T; Carrato A; Puigdomènech E; Real FX;
    Cancer Causes Control; 2009 Jul; 20(5):591-9. PubMed ID: 19083106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer.
    Alguacil J; Porta M; Kauppinen T; Malats N; Kogevinas M; Carrato A;
    Int J Cancer; 2003 Nov; 107(4):635-41. PubMed ID: 14520703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients.
    Uemura T; Hibi K; Kaneko T; Takeda S; Inoue S; Okochi O; Nagasaka T; Nakao A
    J Gastroenterol; 2004 Jan; 39(1):56-60. PubMed ID: 14767735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1.
    Fensterer H; Giehl K; Buchholz M; Ellenrieder V; Buck A; Kestler HA; Adler G; Gierschik P; Gress TM
    Genes Chromosomes Cancer; 2004 Mar; 39(3):224-35. PubMed ID: 14732924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
    Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
    Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.